Name: UMIN ID:
Unique ID issued by UMIN | UMIN000017453 |
---|---|
Receipt number | R000012545 |
Scientific Title | Clinical trial to evaluate the safety of Temsirolimus combined with Vincristine and Irinotecan in children with recurrent/refractory solid tumors |
Date of disclosure of the study information | 2015/05/07 |
Last modified on | 2022/04/13 10:15:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/05/07 17:33:30 | ||
2 | Update | 2015/10/11 12:38:17 | Recruitment status Results Results |
|
3 | Update | 2021/02/12 14:56:57 | ||
4 | Update | 2022/04/13 09:31:51 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Institute Department Organization Organization Category of Funding Organization Organization Organization Address Address Tel |
|
5 | Update | 2022/04/13 10:14:31 | Number of participants that the trial has enrolled Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
6 | Update | 2022/04/13 10:15:44 | Date of IRB |